These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Practice parameters for sublingual immunotherapy. Ortolani C, Agostinis F, Amoroso S, Ariano R, Barbato A, Bassi M, Cadario G, Campi P, Cardinale F, Ciprandi G, D'Anneo R, Di Gioacchino M, Di Rienzo V, Fiocchi A, Galimberti M, Galli E, Giovannini M, Incorvaia C, La Grutta S, Lombardi C, Marcucci F, Marseglia G, Minelli M, Musarra A, Nettis E, Novembre E, Pajno G, Patriarca G, Pezzuto F, Piras P, Pucci S, Romano A, Romano C, Quercia O, Scala G, Schiavino D, Senna G, Sforza G, Tosca M, Tripodi S, Frati F. Monaldi Arch Chest Dis; 2006 Mar; 65(1):44-6. PubMed ID: 16700194 [Abstract] [Full Text] [Related]
23. [Allergic march in children, from rhinitis to asthma: management, indication of immunotherapy]. Scheinmann P, Pham Thi N, Karila C, de Blic J. Arch Pediatr; 2012 Mar; 19(3):330-4. PubMed ID: 22306361 [Abstract] [Full Text] [Related]
25. Treating allergic rhinitis by sublingual immunotherapy: a review. Incorvaia C, Di Rienzo A, Celani C, Makrì E, Frati F. Ann Ist Super Sanita; 2012 Sep; 48(2):172-6. PubMed ID: 22751560 [Abstract] [Full Text] [Related]
26. [Immunotherapy with allergen extracts for allergic rhinitis]. Riechelmann H. HNO; 2005 Jun; 53(6):517-20, 522-6, 528-30. PubMed ID: 15915345 [Abstract] [Full Text] [Related]
28. [Allergen-specific immunotherapy in allergic rhinitis]. Klimek L, Grevers G. MMW Fortschr Med; 2008 Feb 28; 150(9):29-33; quiz 34. PubMed ID: 18402267 [No Abstract] [Full Text] [Related]
29. [Desensitive treatment with positive allergens in acupoints of the head for allergic rhinitis and its mechanism]. Zhou RL, Zhang JC. Zhong Xi Yi Jie He Za Zhi; 1991 Dec 28; 11(12):721-3, 708. PubMed ID: 1821337 [Abstract] [Full Text] [Related]
30. Strategies to treat allergic disease. Bousquet J. Drugs Today (Barc); 2008 Dec 28; 44 Suppl B():25-7. PubMed ID: 19221614 [No Abstract] [Full Text] [Related]
31. [Allergy: who should be hyposensitized? Indications and practice of specific hyposensitization treatment of allergic diseases]. Wüthrich B. ZFA (Stuttgart); 1984 Jan 20; 60(2):67-75. PubMed ID: 6702271 [No Abstract] [Full Text] [Related]
36. [An introduction to the international pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma]. Zhang L. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jul 20; 46(7):611-3. PubMed ID: 22088302 [No Abstract] [Full Text] [Related]
38. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application]. Fuchs T, Klimek L. HNO; 2000 Feb 07; 48(2):158-64. PubMed ID: 10663067 [No Abstract] [Full Text] [Related]
39. Allergen-specific immunotherapy. Present state and directions for the future. Malling HJ. Allergy; 1999 Feb 07; 54 Suppl 50():30-3. PubMed ID: 10466034 [No Abstract] [Full Text] [Related]
40. The efficacy of E.P.D., a new immunotherapy, in the treatment of allergic diseases in children. Caramia G, Franceschini F, Cimarelli ZA, Ciucchi MS, Gagliardini R, Ruffini E. Allerg Immunol (Paris); 1996 Nov 07; 28(9):308-10. PubMed ID: 8986246 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]